December Sees Three Milestones For ViiV’s Pipeline

R&D Chief Outlines 2 FDA Filings, 1 Expected Approval

 
• By Sten Stovall
  
HIV
ViiV is a specialist HIV company • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip